Pancreatic Cancer Research

ResearcherGeorgetown UniversityActive in the last 2 years

Anton Wellstein

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0002-0570-4950; OpenAlex author ID A5076845153. Sources: OpenAlex.

Their work

Papers
12 (first author 0, last author 7)
Trials
0
Grants
0
Labs led
1
Collaborators
24
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: 1 paper · 2015: 2 papers · 2016: 1 paper · 2017: 1 paper · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: none · 2022: 2 papers · 2023: none · 2024: 1 paper · 2025: 1 paper

Papers 12

  1. Pancreatic cancer cell-intrinsic transglutaminase-2 promotes T cell suppression through microtubule-dependent secretion of immunosuppressive cytokines. Co-author DOI 10.1136/jitc-2024-010579↗
  2. A pancreatic cancer organoid-in-matrix platform shows distinct sensitivities to T cell killing. Co-author DOI 10.1038/s41598-024-60107-5↗
  3. Impaired CXCL12 signaling contributes to resistance of pancreatic cancer subpopulations to T cell-mediated cytotoxicity. Last author DOI 10.1080/2162402x.2022.2027136↗
  4. Distinct Response of Circulating microRNAs to the Treatment of Pancreatic Cancer Xenografts with FGFR and ALK Kinase Inhibitors. Last author DOI 10.3390/cancers14061517↗
  5. Immune-Related Circulating miR-125b-5p and miR-99a-5p Reveal a High Recurrence Risk Group of Pancreatic Cancer Patients after Tumor Resection. Last author DOI 10.3390/app9224784↗
  6. Reprint of: Circulating cell-free DNA mutation patterns in early and late stage colon and pancreatic cancer. Last author DOI 10.1016/j.cancergen.2018.11.001↗
  7. Circulating cell-free DNA mutation patterns in early and late stage colon and pancreatic cancer. Last author DOI 10.1016/j.cancergen.2017.08.006↗
  8. Circulating microRNA profile predicts disease progression in patients receiving second-line treatment of lapatinib and capecitabine for metastatic pancreatic c… Co-author DOI 10.3892/ol.2016.4101↗
  9. Distinct serum metabolomics profiles associated with malignant progression in the KrasG12D mouse model of pancreatic ductal adenocarcinoma. Last author DOI 10.1186/1471-2164-16-s1-s1↗
  10. Circulating DNA and Micro-RNA in Patients with Pancreatic Cancer. Co-author DOI 10.4172/2165-7092.1000156↗
  11. Downstream of mutant KRAS, the transcription regulator YAP is essential for neoplastic progression to pancreatic ductal adenocarcinoma. Co-author DOI 10.1126/scisignal.2005049↗
  12. Tissue and serum microRNAs in the Kras(G12D) transgenic animal model and in patients with pancreatic cancer. Last author DOI 10.1371/journal.pone.0020687↗

Closest collaborators

The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Eveline E. Vietsch · 6 shared papers, 2014–2022 · strength 0.67
  2. Tim Eiseler · 2 shared papers, 2024–2025 · strength 0.47
  3. Yuan‐Na Lin · 2 shared papers, 2024–2025 · strength 0.47
  4. Anton Lahusen · 2 shared papers, 2024–2025 · strength 0.47
  5. Alexander Kleger · 2 shared papers, 2024–2025 · strength 0.47
  6. Thomas Theodor Werner Seufferlein · 2 shared papers, 2024–2025 · strength 0.47
  7. Ivana Peran · 4 shared papers, 2011–2022 · strength 0.38
  8. John Lindsay Marshall · 4 shared papers, 2011–2018 · strength 0.25
  9. Giuseppe Giaccone · 2 shared papers, 2017–2018 · strength 0.17
  10. Yuan-Na Lin · 1 shared paper, 2022 · strength 0.16
  11. Fleur van der Sijde · 1 shared paper, 2019 · strength 0.10
  12. Mustafa Suker · 1 shared paper, 2019 · strength 0.10
  13. Casper H.J. van Eijck · 1 shared paper, 2019 · strength 0.10
  14. Joseph J. LaConti · 2 shared papers, 2011–2015 · strength 0.08
  15. Jimmy J. Hwang · 1 shared paper, 2016 · strength 0.05
  16. Aiwu Ruth He · 1 shared paper, 2016 · strength 0.05
  17. Zheng Wu · 1 shared paper, 2016 · strength 0.05
  18. Xue‐Fei Tian · 1 shared paper, 2016 · strength 0.05
  19. Louis M. Weiner · 1 shared paper, 2016 · strength 0.05
  20. Michael Jon Pishvaian · 1 shared paper, 2016 · strength 0.05
  21. Jerry W. Shay · 1 shared paper, 2015 · strength 0.05
  22. Weiying Zhang · 1 shared paper, 2014 · strength 0.03
  23. Chunling Yi · 1 shared paper, 2014 · strength 0.03
  24. Sung Eun Kim · 1 shared paper, 2011 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.